ADS-TEC Energy Reports Financial Results for HY1 2025

Adani Group shares rose after a US court dismissed with prejudice fraud-related charges against Gautam Adani, Sagar Adani and Vneet Jaain. The US District Judge Nicholas Garaufis accepted the DOJ’s narrow “puffery” argument and barred reopening the case. Adani Enterprises gained 2.6% to ₹3,080; Adani Green Energy rose 3.5%. The SEC civil settlement is $18 million.

Adani Enterprises won bids to operate five Indian airports—Ahmedabad, Lucknow, Jaipur, Thiruvananthapuram and Mangalore—after financial bids were opened Monday, according to the report. The government invited bids for 50-year PPP concessions using a per-passenger fee model. Guwahati was stayed by a High Court. Adani’s per-passenger bids were higher than rivals (e.g., Ahmedabad Rs 177 vs GMR Rs 85).

Adani Energy Solutions (AESL) said it signed a binding agreement to buy 100% of smart metering firm IntelliSmart Infrastructure for Rs 3,050 crore, including redemption of optionally convertible debentures held by NIIF. IntelliSmart runs 2.2 crore+ meters across five states. AESL expects the deal to raise its total portfolio to 4.7 crore+ meters, subject to approvals and closing conditions.

Fermi Inc. (NASDAQ:FRMI) said it signed a framework agreement with Hillcore Energy Capital to finance, build, own, and operate a 2.6 GW Hillcore Power Center at Fermi’s Project Matador campus in Texas under a BOOT structure. The complex includes about 2.5 GW natural gas, 100 MW solar, and battery storage. First power is targeted within 24 months of notice to proceed, and Fermi can buy the asset after 10 years at fair market value.

Baker Hughes said it won a multi-year contract with Kuwait Oil Company for the Ahmadi Innovation Valley project. The collaboration makes Baker Hughes a technology partner to develop and deploy scalable upstream solutions, including production optimization and flow assurance, using its digital and AI automation tools. The work targets higher recovery, lower operating costs, reduced water production, and less power use.

Dermata Therapeutics (NASDAQ:DRMA) reported Q2 2026 results and corporate updates. The company said its first commercial product, Tome Foundational Treatment, is expected to launch and begin selling on Aug. 25, 2026, with a second weekly OTC acne product planned later. Cash fell to $4.4M at June 30, 2026 from $7.5M at Dec. 31, 2025.